Atlas Trials

A Study to Desensitize Allergic Reactions to Treatments for Blood Disorders

Clinical trial NCT03959358 · COMPLETED

Trial details

NCT number
NCT03959358
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaAmyloidosis
Start date
2020-07-03
Primary completion
2022-06-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.